Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
102 pg/ml, P = 0.011) with a trend toward significance at day 56 (52 vs. 87 pg/ml, P = 0.050) ( Fig 3A ).
also in 3,729 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.